China, India, US and Japan Drugs for Treatment of Age-related Macular Degeneration Research Report to 2020

 Table of Content


China, India, US and Japan Drugs for Treatment of Age-related Macular Degeneration Research Report to 2020
1 Drugs for Treatment of Age-related Macular Degeneration Overview and Each Type
1.1 Product Overview of Drugs for Treatment of Age-related Macular Degeneration
1.1.1 Definition and Product Scope of Drugs for Treatment of Age-related Macular Degeneration
1.1.2 China Market Size (Value and Volume) of Drugs for Treatment of Age-related Macular Degeneration 2015-2020
1.1.3 India Market Size (Value and Volume) of Drugs for Treatment of Age-related Macular Degeneration 2015-2020
1.1.4 US Market Size (Value and Volume) of Drugs for Treatment of Age-related Macular Degeneration 2015-2020
1.1.5 Japan Market Size (Value and Volume) of Drugs for Treatment of Age-related Macular Degeneration 2015-2020
1.2 Product Segments and Price of Each Type
1.2.1 Product Type of Key Manufacturers
1.2.2 Price List of Each Type in 2015 to 2016
1.2.3 Market Share and Growth Rate of Each Type
1.2.4 Eylea Specification and Price in 2015 and 2016
1.2.5 Conbercept Ophthalmic Injection Specification and Price in 2015 and 2016
1.2.6 Visudyne Specification and Price in 2015 and 2016
1.2.7 Augentropfen Stulln Mono Specification and Price in 2015 and 2016
1.2.8 Pegaptanib Specification and Price in 2015 and 2016
1.2.9 Lucentis Specification and Price in 2015 and 2016
1.2.10 Avastin Specification and Price in 2015 and 2016
1.3 Price List (Interviewed) of Each Type for Key Manufacturers in 2015 and 2016
1.3.1 Price List (Interviewed) of Eylea by Key Manufacturers
1.3.2 Price List (Interviewed) of Conbercept Ophthalmic Injection by Key Manufacturers
1.3.3 Price List (Interviewed) of Visudyne by Key Manufacturers
1.3.4 Price List (Interviewed) of Augentropfen Stulln Mono by Key Manufacturers
1.3.5 Price List (Interviewed) of Pegaptanib by Key Manufacturers
1.3.6 Price List (Interviewed) of Lucentis by Key Manufacturers
1.3.7 Price List (Interviewed) of Avastin by Key Manufacturers
2 Competition Analysis by Manufacturers
2.1 China Market Drugs for Treatment of Age-related Macular Degeneration Sales and Share List of Key Manufacturers 2010 to 2015
2.2 China Market Drugs for Treatment of Age-related Macular Degeneration Revenue and Share List of Key Manufacturers 2010 to 2015
2.3 China Drugs for Treatment of Age-related Macular Degeneration Average Price List of Key Manufacturers 2010 to 2015
2.4 India Market Drugs for Treatment of Age-related Macular Degeneration Sales and Share List of Key Manufacturers 2010 to 2015
2.5 India Market Drugs for Treatment of Age-related Macular Degeneration Revenue and Share List of Key Manufacturers 2010 to 2015
2.6 India Drugs for Treatment of Age-related Macular Degeneration Average Price List of Key Manufacturers 2010 to 2015
2.7 US Market Drugs for Treatment of Age-related Macular Degeneration Sales and Share List of Key Manufacturers 2010 to 2015
2.8 US Market Drugs for Treatment of Age-related Macular Degeneration Revenue and Share List of Key Manufacturers 2010 to 2015
2.9 US Drugs for Treatment of Age-related Macular Degeneration Average Price List of Key Manufacturers 2010 to 2015
2.10 Japan Market Drugs for Treatment of Age-related Macular Degeneration Sales and Share List of Key Manufacturers 2010 to 2015
2.11 Japan Market Drugs for Treatment of Age-related Macular Degeneration Revenue and Share List of Key Manufacturers 2010 to 2015
2.12 Japan Drugs for Treatment of Age-related Macular Degeneration Average Price List of Key Manufacturers 2010 to 2015
3 Sales and Revenue Segments of Each Type 2015 to 2016
3.1 Sales and Revenue Segments of Each Type 2015 to 2016(China, India, US and Japan)
3.1.1 Sales and Market Share of Each Type 2015 to 2016(China, India, US and Japan)
3.1.2 Revenue and Market Share of Each Type 2015 to 2016(China, India, US and Japan)
3.2 Sildenafil Citrate Tablets Sales and Growth Rate 2015 to 2020
3.3 Cialis Sales and Growth Rate 2015 to 2020
3.4 Levitra Sales and Growth Rate 2015 to 2020
3.5 Methyltestosterone Tablets Sales and Growth Rate 2015 to 2020
4 Market Segments and Forecast of Drugs for Treatment of Age-related Macular Degeneration by Regions
4.1 Sales (Consumption) and Forecast of Drugs for Treatment of Age-related Macular Degeneration by Regions 2015-2020
4.1.1 Sales and Forecast of Drugs for Treatment of Age-related Macular Degeneration by Regions 2015-2020
4.1.2 Sales Growth Rate Forecast of Drugs for Treatment of Age-related Macular Degeneration by Regions 2015 to 2020
4.2 Price and Forecast of Drugs for Treatment of Age-related Macular Degeneration by Regions 2015 to 2020
4.2.1 Price and Forecast of Drugs for Treatment of Age-related Macular Degeneration by Regions 2015 to 2020
4.2.2 Price Growth Rate Forecast of Drugs for Treatment of Age-related Macular Degeneration by Regions 2015 to 2020
4.3 China Market Forecast to 2020
4.3.1 China Sales and market share of Drugs for Treatment of Age-related Macular Degeneration 2015 to 2020
4.4 India Market Forecast to 2020
4.4.1 India Sales and market share of Drugs for Treatment of Age-related Macular Degeneration 2015 to 2020
4.5 US Market Forecast to 2020
4.5.1 US Sales and market share of Drugs for Treatment of Age-related Macular Degeneration 2015 to 2020
4.5 Japan Market Forecast to 2020
4.5.1 Japan Sales and market share of Drugs for Treatment of Age-related Macular Degeneration 2015 to 2020
5 Raw Materials and Applications
5.1 Key Raw Materials and Price Analysis for Eylea
5.1.1 Key Raw Materials for Eylea
5.1.2 Price Forecast of Key Raw Materials for Eylea 2016 to 2021
5.2 Key Raw Materials and Price Analysis for Conbercept Ophthalmic Injection
5.2.1 Key Raw Materials for Conbercept Ophthalmic Injection
5.2.2 Price Forecast of Key Raw Materials for Conbercept Ophthalmic Injection 2016 to 2021
5.3 Key Raw Materials and Price Analysis for Verteporfin Powder for Injection
5.3.1 Key Raw Materials for Verteporfin Powder for Injection
5.3.2 Price Forecast of Key Raw Materials for Verteporfin Powder for Injection 2016 to 2021
5.4 Key Raw Materials and Price Analysis for Augentropfen Stulln Mono
5.4.1 Key Raw Materials for Augentropfen Stulln Mono
5.4.2 Price Forecast of Key Raw Materials for Augentropfen Stulln Mono 2016 to 2021
5.5 Key Raw Materials and Price Analysis for Pegaptanib
5.5.1 Key Raw Materials for Pegaptanib
5.5.2 Price Forecast of Key Raw Materials for Pegaptanib 2016 to 2021
5.6 Key Raw Materials and Price Analysis for Lucentis
5.6.1 Key Raw Materials for Lucentis
5.6.2 Price Forecast of Key Raw Materials for Lucentis 2016 to 2021
5.7 Key Raw Materials and Price Analysis for Avastin
5.7.1 Key Raw Materials for Avastin
5.7.2 Price Forecast of Key Raw Materials for Avastin2016 to 2021
6 Key Manufacturers Analysis of Drugs for Treatment of Age-related Macular Degeneration
6.1 Regeneron
6.1.1 Company Basic Information
6.1.2 Eylea (Specification and Price)
6.1.2.1 Eylea 2mg/0.05ml, Price, Sales Value and Market Share of Regeneron
6.1.3 Sales Value, Gross Margin 2011-2016
6.1.3.1 Sales Value, Gross Margin and Growth rate of Regeneron Eylea 2mg/0.05ml
6.1.4 Interviewee, Name and Contact
6.2 Bayer
6.2.1 Company Basic Information
6.2.2 Eylea (Specification and Price)
6.2.2.1 Eylea 2mg/0.05ml, Price, Sales Value and Market Share of Bayer
6.2.3 Sales Value, Gross Margin 2011-2016
6.2.3.1 Sales Value, Gross Margin and Growth rate of Bayer Eylea 2mg/0.05ml
6.2.4 Interviewee, Name and Contact
6.3 Chengdu Kanghong Biotechnologies
6.3.1 Company Basic Information
6.3.2 Conbercept Ophthalmic Injection (Specification and Price)
6.3.2.1 Conbercept Ophthalmic Injection 2mg/0.2ml, Price, Sales Value and Market Share of Chengdu Kanghong Biotechnologies
6.3.2.2 Conbercept Ophthalmic Injection 10mg/1ml, Price, Sales Value and Market Share of Chengdu Kanghong Biotechnologies
6.3.3 Sales Value, Gross Margin 2011-2016
6.3.3.1 Sales Value, Gross Margin and Growth rate of Chengdu Kanghong Biotechnologies Conbercept Ophthalmic Injection 2mg/0.2ml
6.3.3.2 Sales Value, Gross Margin and Growth rate of Chengdu Kanghong Biotechnologies Conbercept Ophthalmic Injection 10mg/1ml
6.3.4 Interviewee, Name and Contact
6.4 Pharma Stulln GmbH
6.4.1 Company Basic Information
6.4.2 Augentropfen Stulln Mono (Specification and Price)
6.4.2.1 Augentropfen Stulln Mono 0.4ml:0.006mg:0.040mg, Price, Sales Value and Market Share of Pharma Stulln GmbH
6.4.3 Sales Value, Gross Margin 2011-2016
6.4.3.1 Sales Value, Gross Margin and Growth rate of Pharma Stulln GmbH Levitra Augentropfen Stulln Mono 0.4ml:0.006mg:0.040mg
6.4.4 Interviewee, Name and Contact
6.5 Pfizer
6.5.1 Company Basic Information
6.5.2 Pegaptanib (Specification and Price)
6.5.2.1 Pegaptanib EQ 0.3MG ACID/0.09ML, Price, Sales Value and Market Share of Pfizer
6.5.3 Sales Value, Gross Margin 2011-2016
6.5.3.1 Sales Value, Gross Margin and Growth rate of  Pfizer Pegaptanib EQ 0.3MG ACID/0.09ML
6.5.4 Interviewee, Name and Contact
6.6 Eyetech
6.6.1 Company Basic Information
6.6.2 Pegaptanib (Specification and Price)
6.6.2.1 Pegaptanib EQ 0.3MG ACID/0.09ML, Price, Sales Value and Market Share of Eyetech
6.6.3 Sales Value, Gross Margin 2011-2016
6.6.3.1 Sales Value, Gross Margin and Growth rate of Eyetech Pegaptanib EQ 0.3MG ACID/0.09ML
6.6.4 Interviewee, Name and Contact
6.7 Intas
6.7.1 Company Basic Information
6.7.2 Razumab (Specification and Price)
6.7.2.1 Razumab10mg/ml, Price, Sales Value and Market Share of Intas
6.7.3 Sales Value, Gross Margin 2011-2016
6.7.3.1 Sales Value, Gross Margin and Growth rate of  Intas Razumab10mg/ml
6.7.4 Interviewee, Name and Contact
6.8 Novartis Pharma
6.8.1 Company Basic Information
6.8.2 Lucentis (Specification and Price)
6.8.2.1 Lucentis10mg/ml, Price, Sales Value and Market Share of Novartis Pharma
6.8.3 Sales Value, Gross Margin 2011-2016
6.8.3.1 Sales Value, Gross Margin and Growth rate of Novartis Pharma Lucentis10mg/ml
6.8.4 Interviewee, Name and Contact
6.9 Roche
6.9.1 Company Basic Information
6.9.2 Lucentis (Specification and Price)
6.9.2.1 Lucentis10mg/ml, Price, Sales Value and Market Share of Roche
6.9.3 Sales Value, Gross Margin 2011-2016
6.9.3.1 Sales Value, Gross Margin and Growth rate of Roche Lucentis10mg/ml
6.9.4 Interviewee, Name and Contact
6.10 LUCKY PHARMA
6.10.1 Company Basic Information
6.10.2 Lucentis (Specification and Price)
6.10.2.1 Lucentis10mg/ml, Price, Sales Value and Market Share of LUCKY PHARMA
6.10.3 Sales Value, Gross Margin 2011-2016
6.10.3.1 Sales Value, Gross Margin and Growth rate of LUCKY PHARMA Lucentis10mg/ml
6.10.4 Interviewee, Name and Contact
6.11 Novartis Pharma
6.11.1 Company Basic Information
6.11.2 Visudyne (Specification and Price)
6.11.2.1 Visudyne 15mg, Price, Sales Value and Market Share of Novartis Pharma
6.11.3 Sales Value, Gross Margin 2011-2016
6.11.3.1 Sales Value, Gross Margin and Growth rate of Novartis Pharma Visudyne15mg
6.11.4 Interviewee, Name and Contact
6.12 Whyte Chemicals
6.12.1 Company Basic Information
6.12.2 Verteporfin Powder for Injection (Specification and Price)
6.12.2.1 Verteporfin Powder for Injection 15mg, Price, Sales Value and Market Share of Whyte Chemicals
6.12.3 Sales Value, Gross Margin 2011-2016
6.12.3.1 Sales Value, Gross Margin and Growth rate of Whyte Chemicals Verteporfin Powder for Injection15mg
6.12.4 Interviewee, Name and Contact
6.13 KEMPROTEC
6.13.1 Company Basic Information
6.13.2 Verteporfin Powder for Injection (Specification and Price)
6.13.2.1 Verteporfin Powder for Injection 15mg, Price, Sales Value and Market Share of KEMPROTEC
6.13.3 Sales Value, Gross Margin 2011-2016
6.13.3.1 Sales Value, Gross Margin and Growth rate of KEMPROTEC Verteporfin Powder for Injection15mg
6.13.4 Interviewee, Name and Contact
6.14 LGM Pharma
6.14.1 Company Basic Information
6.14.2 Verteporfin Powder for Injection (Specification and Price)
6.14.2.1 Verteporfin Powder for Injection 15mg, Price, Sales Value and Market Share of LGM Pharma
6.14.3 Sales Value, Gross Margin 2011-2016
6.14.3.1 Sales Value, Gross Margin and Growth rate of LGM Pharma Verteporfin Powder for Injection15mg
6.14.4 Interviewee, Name and Contact
6.15 MedChemexpress LLC
6.15.1 Company Basic Information
6.15.2 Verteporfin Powder for Injection (Specification and Price)
6.15.2.1 Verteporfin Powder for Injection 15mg, Price, Sales Value and Market Share of MedChemexpress LLC
6.15.3 Sales Value, Gross Margin 2011-2016
6.15.3.1 Sales Value, Gross Margin and Growth rate of MedChemexpress LLC Verteporfin Powder for Injection15mg
6.15.4 Interviewee, Name and Contact
6.16 BOC Sciences
6.16.1 Company Basic Information
6.16.2 Verteporfin Powder for Injection (Specification and Price)
6.16.2.1 Verteporfin Powder for Injection 15mg, Price, Sales Value and Market Share of BOC Sciences
6.16.3 Sales Value, Gross Margin 2011-2016
6.16.3.1 Sales Value, Gross Margin and Growth rate of BOC Sciences Verteporfin Powder for Injection15mg
6.16.4 Interviewee, Name and Contact
6.17 Alfa Chemistry
6.17.1 Company Basic Information
6.17.2 Verteporfin Powder for Injection (Specification and Price)
6.17.2.1 Verteporfin Powder for Injection 15mg, Price, Sales Value and Market Share of Alfa Chemistry
6.17.3 Sales Value, Gross Margin 2011-2016
6.17.3.1 Sales Value, Gross Margin and Growth rate of Alfa Chemistry Verteporfin Powder for Injection15mg
6.17.4 Interviewee, Name and Contact
6.18 Roche
6.18.1 Company Basic Information
6.18.2 Avastin (Specification and Price)
6.16.2.1 Avastin 100mg(4ml)/bottle, Price, Sales Value and Market Share of Roche
6.16.2.2 Avastin 400mg(16ml)/bottle, Price, Sales Value and Market Share of Roche
6.18.3 Sales Value, Gross Margin 2011-2016
6.18.3.1 Sales Value, Gross Margin and Growth rate of Roche Avastin 100mg(4ml)/bottle
6.18.3.2 Sales Value, Gross Margin and Growth rate of Roche Avastin 400mg(16ml)/bottle
6.18.4 Interviewee, Name and Contact
7 Technology Development Trend
7.1 Manufacturing Process of Drugs for Treatment of Erectile Dysfunction
7.2 Analysis of Manufacturing Process
7.3 Development Trend
8 Worldwide, an estimated time for the drug in Erectile Dysfunction research to market
9 Patent expiration time analysis
9.1 Viagra patent expires in China and sales
9.2 Cialis patent expires in China and sales
9.3 Levitra patent expires in China and sales
10 Research Findings and Conclusion

List of Tables and Figures


Figure Picture of Drugs for Treatment of Age-related Macular Degeneration
Figure China Market Size (Value) of Drugs for Treatment of Age-related Macular Degeneration 2015-2020
Figure China Market Size (Volume) of Drugs for Treatment of Age-related Macular Degeneration 2015-2020
Figure India Market Size (Value) of Drugs for Treatment of Age-related Macular Degeneration2015-2020
Figure India Market Size (Volume) of Drugs for Treatment of Age-related Macular Degeneration 2015-2020
Figure US Market Size (Value) of Drugs for Treatment of Age-related Macular Degeneration2015-2020
Figure US Market Size (Volume) of Drugs for Treatment of Age-related Macular Degeneration 2015-2020
Figure Japan Market Size (Value) of Drugs for Treatment of Age-related Macular Degeneration2015-2020
Figure Japan Market Size (Volume) of Drugs for Treatment of Age-related Macular Degeneration 2015-2020
Table Product Type of Key Manufacturers
Table Price List of Each Type
Table Market Share of Each Type
Figure Growth Rate of Each Type 2015 to 2016
Figure Picture of Eylea
Table Specification and Price of Eylea in 2015 and 2016
Figure Picture of Conbercept Ophthalmic Injection
Table Specification and Price of Cialis in 2015 and 2016
Figure Picture of Visudyne
Table Specification and Price of Visudyne in 2015 and 2016
Figure Picture of Augentropfen Stulln Mono
Table Specification and Price of Augentropfen Stulln Mono in 2015 and 2016
Figure Picture of Pegaptanib
Table Specification and Price of Pegaptanib in 2015 and 2016
Figure Picture of Lucentis
Table Specification and Price of Lucentis in 2015 and 2016
Figure Picture of Avastin
Table Specification and Price of Avastin in 2015 and 2016
Table Price List (Interviewed) of Eylea by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Cialis by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Visudyne by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Augentropfen Stulln Mono Tablets by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Pegaptanib Tablets by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Lucentis Tablets by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Avastin Tablets by Key Manufacturers in 2015 and 2016
Table China Market Drugs for Treatment of Age-related Macular Degeneration Sales List of Key Manufacturers 2010 to 2015
Table China Market Drugs for Treatment of Age-related Macular Degeneration Sales Share List of Key Manufacturers 2010 to 2015
Table China Market Drugs for Treatment of Age-related Macular Degeneration Revenue List of Key Manufacturers 2010 to 2015
Table China Market Drugs for Treatment of Age-related Macular Degeneration Revenue Share List of Key Manufacturers 2010 to 2015
Table China Drugs for Treatment of Age-related Macular Degeneration Average Price List of Key Manufacturers 2010 to 2015
Table India Market Drugs for Treatment of Age-related Macular Degeneration Sales List of Key Manufacturers 2010 to 2015
Table India Market Drugs for Treatment of Age-related Macular Degeneration Sales Share List of Key Manufacturers 2010 to 2015
Table India Market Drugs for Treatment of Age-related Macular Degeneration Revenue List of Key Manufacturers 2010 to 2015
Table India Market Drugs for Treatment of Age-related Macular Degeneration Revenue Share List of Key Manufacturers 2010 to 2015
Table India Drugs for Treatment of Age-related Macular Degeneration Average Price List of Key Manufacturers 2010 to 2015
Table US Market Drugs for Treatment of Age-related Macular Degeneration Sales List of Key Manufacturers 2010 to 2015
Table US Market Drugs for Treatment of Age-related Macular Degeneration Sales Share List of Key Manufacturers 2010 to 2015
Table US Market Drugs for Treatment of Age-related Macular Degeneration Revenue List of Key Manufacturers 2010 to 2015
Table US Market Drugs for Treatment of Age-related Macular Degeneration Revenue Share List of Key Manufacturers 2010 to 2015
Table US Drugs for Treatment of Age-related Macular Degeneration Average Price List of Key Manufacturers 2010 to 2015
Table Japan Market Drugs for Treatment of Age-related Macular Degeneration Sales List of Key Manufacturers 2010 to 2015
Table Japan Market Drugs for Treatment of Age-related Macular Degeneration Sales Share List of Key Manufacturers 2010 to 2015
Table Japan S Market Drugs for Treatment of Age-related Macular Degeneration Revenue List of Key Manufacturers 2010 to 2015
Table Japan Market Drugs for Treatment of Age-related Macular Degeneration Revenue Share List of Key Manufacturers 2010 to 2015
Table Japan Drugs for Treatment of Age-related Macular Degeneration Average Price List of Key Manufacturers 2010 to 2015
Table Sales of Each Type 2015 to 2016(China, India, US and Japan)
Table Sales Market Share of Each Type 2015 to 2016(China, India, US and Japan)
Table Global Revenue of Each Type 2015 to 2016(China, India, US and Japan)
Table Revenue Market Share of Each Type 2015 to 2016(China, India, US and Japan)
Figure Sildenafil Citrate Tablets Sales and Growth Rate 2015 to 2020
Figure Cialis Sales and Growth Rate 2015 to 2020
Figure Levitra Sales and Growth Rate 2015 to 2020
Figure Methyltestosterone Tablets Sales and Growth Rate 2015 to 2020
Table Sales and Forecast of Drugs for Treatment of Age-related Macular Degeneration by Regions 2015-2020
Figure Sales Growth Rate Forecast of Drugs for Treatment of Age-related Macular Degeneration by Regions 2015 to 2020
Table Price and Forecast of Drugs for Treatment of Age-related Macular Degeneration by Regions 2015 to 2020
Figure Price Growth Rate Forecast of Drugs for Treatment of Age-related Macular Degeneration by Regions 2015 to 2020
Table China Sales and market share of Drugs for Treatment of Erectile Dysfunction 2015 to 2020
Table India Sales and market share of Drugs for Treatment of Age-related Macular Degeneration 2015 to 2020
Table US Sales and market share of Drugs for Treatment of Age-related Macular Degeneration 2015 to 2020
Table Japan Sales and market share of Drugs for Treatment of Age-related Macular Degeneration 2015 to 2020
Table Key Raw Materials for Eylea
Table Price Forecast of Key Raw Materials for Eylea
Table Key Raw Materials for Conbercept Ophthalmic Injection
Table Price Forecast of Key Raw Materials for Conbercept Ophthalmic Injection
Table Key Raw Materials for Verteporfin Powder for Injection
Table Price Forecast of Key Raw Materials for Verteporfin Powder for Injection
Table Key Raw Materials for Augentropfen Stulln Mono
Table Price Forecast of Key Raw Materials for Augentropfen Stulln Mono
Table Key Raw Materials for Pegaptanib
Table Price Forecast of Key Raw Materials for Pegaptanib
Table Key Raw Materials for Lucentis
Table Price Forecast of Key Raw Materials for Lucentis
Table Key Raw Materials for Avastin
Table Price Forecast of Key Raw Materials for Avastin
Table Regeneron Basic Information List
Table Bayer Basic Information List
Table Chengdu Kanghong Biotechnologies Basic Information List
Table Pharma Stulln GmbH Basic Information List
Table Pfizer by Share Ltd Basic Information List
Table Eyetech Basic Information List
Table Intas Basic Information List
Table Novartis Pharma Basic Information List
Table Roche Basic Information List
Table LUCKY PHARMA Basic Information List
Table Novartis Pharma Basic Information List
Table Whyte Chemicals Basic Information List
Table KEMPROTEC Basic Information List
Table LGM Pharma Basic Information List
Table MedChemexpress LLC Basic Information List
Table BOC Sciences Basic Information List
Table Alfa Chemistry Basic Information List
Table Roche Basic Information List

 

To request a free sample copy of this report, please complete the form below.

Enter captcha code*

We never share your personal data. Privacy policy